top of page

台灣安美睿附屬於美國Amarex Clinical Research, LLC.,


28 March 2024

Amarex to Exhibit at the Maryland Business Showcase | March 28 | Laurel, MD

Germantown, MD, USA (March 18, 2024) – Amarex Clinical Research, LLC, an NSF Company, is pleased to announce it will exhibit at the Maryland Tech Council (MTC) Maryland Business Showcase on Thursday, March 28 at 5:30 PM at the Maryland Jockey Club in Laurel, MD.

23 February 2024

Amarex Client Receives U.S. FDA Marketing Approval for Hemoconcentrators 

Germantown, MD, USA (February 23, 2024) – Amarex Clinical Research, LLC, an NSF company is pleased to announce its client Tecnoideal America, Inc. received U.S. FDA 510(k) clearance for hemoconcentrators used in adult patients during or after cardiopulmonary bypass surgery to remove excess fluids from the blood and restore physiological blood conditions. This product successfully completed performance and substantial equivalence testing, and the data proved the device to be substantially equivalent to the predicate device. 

02 February 2024

Amarex Celebrates Its 25th Anniversary!

Germantown, MD, USA (February 02, 2024) – Amarex Clinical Research, LLC, an NSF company, announces December 2023 marked its 25th year advancing patient access to safe and effective clinical products through delivery of outstanding regulatory and clinical trial services to Sponsors within the life sciences industry.

20220218 picture 1_edited.jpg
17 February 2022

Amarex Taiwan Chief Operating Officer, Dr. Chia-Hua Maggie Ho, Featured in 2021 End-of-year Global Bio Investment Article: Bringing U.S. FDA Review Criteria to the Taiwanese Biotech Industry

Taipei, Taiwan (February 17) - Many non-COVID-19 global clinical trials are delayed or terminated early due to the COVID-19 pandemic. The clinical trials carried out by Amarex were not forced to be suspended or terminated during the pandemic. Amarex set up the monitoring plan and audit system remotely and that not only overcomes the difficulty of on-site monitoring but also ensures the quality of clinical trials and the safety and rights of subjects.

02 November 2021

Amarex Taiwan Exhibiting at BIO Asia-Taiwan 2021 | Nov. 4-7 | Taipei, Taiwan

​Taipei, Taiwan (November 02, 2021) – We are pleased to announce that Amarex Taiwan, LLC is exhibiting at BIO Asia-Taiwan 2021, held November 4-7 at the Taipei Nangang Exhibition Center in Taiwan.

16 September2021

Amarex Passes Taiwan FDA GTP Audit: Result is a Resounding No Findings

Taipei, Taiwan (September 16, 2021) – Amarex Taiwan, LLC announces a no findings result of a Taiwan Food and Drug Administration (TFDA) audit of its office last month.

Covid 19
24 February 2021

Amarex Featured in 15-year Anniversary Issue of the NSF International Journal

The just released Issue 48 of NSF International’s Health Science Journal features contributions by Amarex. The journal is available at

Young Businesswoman
15 February 2021

Amarex Job Openings at the BioCapital Life Sciences Career Fair | Feb. 18, 2021

We are featuring current job openings at the MD Tech Council BioCapital Life Sciences Career Fair, Thursday, February 18th. This virtual event is free and open to all students and job seekers interested in career opportunities in the life sciences industry. Register for this virtual event, visit our booth, and speak to an Amarex representative about expanding your career:

25 January 2021

Enrichment Strategies to Increase the Power/Reduce the Sample Size in Clinical Trials

On January 07, Dr. Kazem Kazempour, President & CEO, conducted the webinar Enrichment Strategies to Increase the Power/Reduce the Sample Size in Clinical Trials. View the full webinar recording on our YouTube channel.

  • LinkedIn Social Icon
  • Facebook
  • Twitter
  • YouTube









感謝Amarex團隊給予我們的試驗數據統計支持,其在FDA的最終審核中證明是非常寶貴且完全準確的,這一富含里程碑意義之成就的基石是來自於臨床研究的數據,並包括了檢測極限的研究,我們通過FDA所有的審查,並在整個過程中取得了扎實的結果。 在這裡,我們所有人都真誠地感謝Amarex團隊中所有參與這個專案的人,等到未來我們成功的將平台應用於其他醫療診斷器材的開發時,希望能與您再次合作。



bottom of page